BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 7455507)

  • 21. [Schistosomiasis: clinical spectrum of the disease and response to oxamniquine treatment in chronic infections].
    García Goyco C; Torres Borges A
    Bol Asoc Med P R; 1982 Apr; 74(4):126-8. PubMed ID: 6960899
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N; Rocha RS; Lambertucci JR; Greco DB; Pedroso ER; Rocha MO; Flan S
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):173-7. PubMed ID: 6361966
    [No Abstract]   [Full Text] [Related]  

  • 23. Migration and fate of Schistosoma mansoni in mice treated with oxaminiquine.
    Oliveira MA; Pellegrino J; Pereira LH; Valadares TE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):298-300. PubMed ID: 1006062
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni].
    de Almeida FM; Vilela MP; Pricoli TI; Salem N; Guimarães RX; Ferraz CN; Arroyo JB; Fukuda Y; Cabeca M; Geocze S; Tancredi Neto A
    AMB Rev Assoc Med Bras; 1979 Mar; 25(3):101-4. PubMed ID: 315583
    [No Abstract]   [Full Text] [Related]  

  • 25. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
    Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK
    AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642
    [No Abstract]   [Full Text] [Related]  

  • 26. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni by the oogram method with biopsy of rectal mucosa].
    da Cunha AS
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):88-94. PubMed ID: 6753086
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of oxamniquine on some biological features of schistosomiasis in white mice.
    Hammouda NA; El-Ridi AM; Abu Senna HO; Nasr NT; El-Sawi MF; El-Sawi M; Salama MM
    J Egypt Soc Parasitol; 1983 Jun; 13(1):147-53. PubMed ID: 6631092
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of long-term salmonellosis with oxamniquine].
    Amato Neto V; Basile MA; de Carvalho SA; de Almeida JW; Shiroma M; Hutzler RU
    Rev Inst Med Trop Sao Paulo; 1979; 21(3):137-40. PubMed ID: 504893
    [No Abstract]   [Full Text] [Related]  

  • 31. Fatal hepatic necrosis in association with hycanthone.
    Hatchuel W
    S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of oxamniquine in treatment of S. mansoni in a closed community in Egypt and the concomitant administration of both metrifonate and oxamniquine in mixed infections.
    Saif M; Gaber A; Hassanein YS; Khameis S
    J Egypt Med Assoc; 1978; 61(5-6):427-31. PubMed ID: 400362
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
    Queinnec J; Moyroud J
    Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxamniquine (Vansil) in the treatment of schistosomiasis in Rhodesia.
    de Clarke V
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):28-31, 144-7. PubMed ID: 7455506
    [No Abstract]   [Full Text] [Related]  

  • 35. [Oxamniquine in the treatment of Schistosoma mansoni infection].
    Kapend'a K; Odio W; Toko AL; Vandepitte J; Kayembe NN; Wane J
    Ann Soc Belg Med Trop; 1982; 62(3):213-9. PubMed ID: 7181541
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R; Pinto PL; de Sant'Ana EJ; Moreira AA; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):201-3. PubMed ID: 3135570
    [No Abstract]   [Full Text] [Related]  

  • 38. Further experience on the use of oxamniquine in the treatment of advanced intestinal schistosomiasis.
    Farid Z; Bassily S; Higashi GI; el-Masry NA; Watten RH; Trabolsi B
    Ann Trop Med Parasitol; 1979 Oct; 73(5):501-2. PubMed ID: 534452
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxamniquine in the treatment of various schistosome infections in South Africa.
    Pitchford RJ; Lewis M
    S Afr Med J; 1978 Apr; 53(17):677-80. PubMed ID: 354047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The liver after oxamniquine treatment of schistosomiasis.
    Andrade ZA; dos Santos HA; Grimaud JA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):37-40, 153-6. PubMed ID: 7455508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.